Cogent Biosciences, Inc. (COGT)
38.07
-0.81
(-2.08%)
USD |
NASDAQ |
Dec 29, 14:49
Cogent Biosciences Shareholders Equity (Quarterly): 302.46M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Cidara Therapeutics, Inc. | 422.39M |
| Olema Pharmaceuticals, Inc. | 307.49M |
| ADMA Biologics, Inc. | 431.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 425.93M |
| Total Liabilities (Quarterly) | 123.47M |
| Debt to Equity Ratio | 0.2002 |
| Current Ratio | 6.382 |
| Net Debt Paydown Yield | -0.42% |